Why Patients Stop Meds: It's Identity, Not Forgetting — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Marcela Gottschald, a Brazilian journalist and clinical pharmacist based in Argentina, writes that her experience across psychiatry, a kidney transplant center, cardiology, and primary care revealed that nonadherence stemmed from identity and control concerns, not just forgetfulness or side effects.
- Patients commonly offered familiar explanations like "I forgot," but once guilt and shame eased, many disclosed worries about depending on medication, losing control over their bodies, or needing to prove they could function without it.
- A 23-year-old kidney transplant recipient initially said he forgot his immunosuppressants during work travel; in a hallway conversation he revealed his girlfriend was pregnant and he felt he needed to "become a man," making daily pills feel incompatible with adulthood.
- In mental health care, patients described a harder-to-define problem than typical side effects: a feeling that medication changed who they were, as if an important part of their personality had shifted.
- A 2024 systematic review on illness identity cited in the essay found that how people integrate chronic illness into their sense of self was associated with whether they could manage their health problems and adapt to treatment.
- Gottschald argues that medication beliefs often take root before the first dose is taken, and urges clinicians to ask "What does this medication mean to you?" or "Is there a part of you that resists depending on this treatment?" rather than only checking on missed doses and side effects.
Why it matters: For clinicians treating chronic conditions, this reframes nonadherence as an identity and self-image problem rather than a simple compliance failure — meaning the standard "did you forget?" check may miss the real barrier. The 2024 illness-identity review gives this clinical observation a research backbone, suggesting adherence support may need to begin before the first prescription rather than after patients stop showing up.
Ask SkimNews
